Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Maravai LifeSciences Holdings, Inc. (MRVI) had Free Cash Flow per Share of $0.03 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$65.84M |
|
$-3.73M |
|
$32.14M |
|
$33.70M |
|
$68.00M |
|
$-2.16M |
|
$-4.37M |
|
$-6.53M |
|
$-6.53M |
|
$-6.38M |
|
$-6.38M |
|
$-6.38M |
|
$-6.38M |
|
$-2.16M |
|
$10.82M |
|
146.43M |
|
146.43M |
|
$-0.02 |
|
$-0.02 |
|
| Balance Sheet Financials | |
$251.74M |
|
$146.93M |
|
$461.48M |
|
$713.22M |
|
$42.62M |
|
$265.44M |
|
$301.51M |
|
$344.13M |
|
$369.08M |
|
$94.77M |
|
$369.08M |
|
258.18M |
|
| Cash Flow Statement Financials | |
$8.66M |
|
$-4.44M |
|
$-55.23M |
|
$216.89M |
|
$165.92M |
|
$-50.97M |
|
$6.74M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.91 |
|
-- |
|
-- |
|
0.42 |
|
0.73 |
|
51.19% |
|
-3.28% |
|
-3.28% |
|
-- |
|
-9.92% |
|
-5.67% |
|
$4.23M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
0.79 |
|
1.97 |
|
45.68 |
|
-1.73% |
|
-6.73% |
|
-0.89% |
|
-1.00% |
|
$1.43 |
|
|
Free Cash Flow per Share |
$0.03 |
$0.06 |
|